New Obagi Product
The ELASTIderm(TM) Decolletage System is the newest addition to the trusted ELASTIderm family of physician-dispensed skincare products.
“The new ELASTIderm Decolletage System applies the unique and efficacious technology that exists in our ELASTIderm Eye Cream to address an area in the aesthetics market that is a real source of frustration for so many women,” said Rick Kozloski, Vice President, Marketing and Dermatology for Obagi Medical Products. “The delicate neck and chest area is often untreated in the anti-aging process and this new system can assist skin care professionals in providing the total rejuvenating results their patients want.”
The ELASTIderm(TM) Decolletage System consists of two clinically proven topical skin treatments — ELASTIderm Skin Lightening Complex and ELASTIderm Wrinkle Reducing Lotion. The ELASTIderm Skin Lightening Complex is formulated with 4% hydroquinone to aid in the gradual lightening of hyperpigmented skin conditions. The ELASTIderm Wrinkle Reducing Lotion is formulated with a proprietary bi-mineral complex with malonic acid that helps replenish elasticity and build collagen.
“The ELASTIderm(TM) Decolletage System uses Obagi Medical Product’s exclusive Penetrating Therapeutics(TM), an effective patented technology that allows for greater penetration of an active agent across the skin barrier to stimulate functional elasticity and resilient strength of the skin,” said Steve Carlson, President and Chief Executive Officer of Obagi Medical Products. “We’ve designed the system so that each ingredient can play a critical role in helping to restore elasticity and collagen to help stimulate the production of healthy skin cells, which bolsters Obagi’s position as the leader in elastin science.”
The ELASTIderm(TM) Decolletage System is an easy to use two-step system which should be applied once in the morning and once in the evening or as directed by a skin care professional. The ELASTIderm(TM) Decolletage System is available through dermatologists’ and plastic surgeons’ offices nationwide.
Related Posts:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.



[…] You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your ownsite. […]